Viewing nowCombinationOlmesartan Medoxomil/Amlodipine Tablet 5/40 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.

MFDS item code 201500379 · Approved 2015.01.26 · Insurance code 649508520
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension may use this medication if blood pressure is not adequately controlled by monotherapy with amlodipine or olmesartan medoxomil. This drug effectively manages hypertension to stabilize blood pressure and reduce cardiovascular burden. Consistent use contributes to improving hypertension and preventing complications. Therefore, this medication is used for treating essential hypertension.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medication may be considered. The maximum dose of this medication is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min), the maximum dose of olmesartan medoxomil is 20 milligrams once daily. Use of this medication is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This medication should not be administered to patients with severe hepatic impairment. (See section 2. Patients who should not receive this medication, under Precautions for Use.) ∘Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and coexisting diseases. In elderly patients, blood pressure should be monitored closely and more frequently.
∘Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it must be promptly discontinued upon confirmation of pregnancy. Do not use this medication if you are allergic to any of its active ingredients or similar substances, are pregnant or breastfeeding, have serious liver or heart problems, or are undergoing kidney dialysis. Caution is required when administering this drug to patients who are dehydrated or depleted of electrolytes, as blood pressure may drop too low; appropriate measures should be taken if hypotension develops. Because this medication can cause vasodilation leading to a sudden drop in blood pressure, patients with heart valve issues should use it with caution. Use of this medication should be approached with caution in patients with weakened heart function, and those with impaired kidney function should be closely monitored for changes in renal function. Patients with impaired liver function should also use this medication cautiously, as it is metabolized by the liver and may affect liver function. While taking this medication, dizziness, headache, hypotension, edema, dyspepsia, skin rash, and other side effects may occur; any unusual symptoms should prompt immediate consultation with a physician. This medication may interact with many other drugs; if you are taking any other medications, be sure to inform your doctor or pharmacist. Avoid using this medication during pregnancy; if you are planning to become pregnant or are pregnant, discuss alternative treatment options. For breastfeeding women, it is recommended to discontinue breastfeeding or to stop the medication as it may be excreted in breast milk. Safety and efficacy have not been established for children under 18 years of age, and its use is not recommended. Elderly patients (65 years and older) may have increased sensitivity to this medication, so dosage adjustments and careful monitoring are necessary. In case of overdose, there may be a rapid drop in blood pressure and increased heart rate, necessitating immediate medical attention, along with continuous monitoring of blood pressure and heart function. This medication should be kept out of reach of children, stored in a tightly sealed container, and protected from direct sunlight and moisture. Avoid transferring to other containers.
Drug hypersensitivity, hyperkalemia, decreased libido, dizziness, headache, orthostatic hypotension, drowsiness, paresthesia, diminished perception, syncope, vertigo, palpitations, rapid pulse, hypotension, orthostatic hypotension, dyspnea, cough, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, upper abdominal pain, rash, urticaria, muscle tension, limb pain, low back pain, frequent urination, erectile dysfunction, peripheral edema, edema, pit edema, fatigue, asthenia, facial edema, decreased serum potassium, increased serum creatinine, increased serum uric acid, increased gamma-glutamyltransferase, decreased hemoglobin and hematocrit, low back pain, bronchitis, increased creatine kinase, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, asthenia, angioedema, chronic malabsorption syndrome-like intestinal disease, intestinal vascular edema, rhabdomyolysis, acute renal failure, rising serum creatinine, hair loss, itching, autoimmune hepatitis, flushing, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, nausea, gynecomastia, jaundice, elevated liver enzymes, leukopenia, thrombocytopenia, toxic epidermal necrolysis, non-cardiogenic pulmonary edema, hypotension, tachycardia, bradycardia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's effectiveness and prevent degradation.
Pale yellow, round film-coated tablet
28 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Korea Hyuntex Pharmaceutical Co., Ltd.
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilseong IS Co., Ltd.
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.